A Study of Lianxiaxiaopi Granules in the Treatment of Postprandial Distress Syndrome

NCT06696261 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

342

Enrollment

INDUSTRY

Sponsor class

Conditions

Postprandial Distress Syndrome

Interventions

DRUG: Lianxiaxiaopi Granules
DRUG: a simulated agent of Lianxiaxiaopi Granules

Sponsor

Tasly Pharmaceutical Group Co., Ltd